Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
PHASE2CompletedINTERVENTIONAL
Enrollment
45
Participants
Timeline
Start Date
October 31, 2007
Primary Completion Date
May 31, 2011
Conditions
Head and Neck Cancer
Interventions
BIOLOGICAL
cetuximab
RADIATION
stereotactic body radiation therapy
Trial Locations (1)
59020
Centre Oscar Lambret, Lille
All Listed Sponsors
lead
Centre Oscar Lambret
OTHER
NCT00738868 - Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter